Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tissue Transplantation | 1 | 2017 | 5 | 0.74 | Why? |
| Febrile Neutropenia | 1 | 2019 | 179 | 0.67 | Why? |
| Administration, Intranasal | 1 | 2021 | 1132 | 0.62 | Why? |
| Papillomaviridae | 2 | 2017 | 404 | 0.61 | Why? |
| Eye Banks | 1 | 2017 | 167 | 0.61 | Why? |
| Cytomegalovirus Infections | 2 | 2018 | 667 | 0.54 | Why? |
| Hearing Loss | 1 | 2017 | 225 | 0.52 | Why? |
| India | 16 | 2021 | 11875 | 0.40 | Why? |
| Uterine Cervical Neoplasms | 1 | 2017 | 842 | 0.36 | Why? |
| Eye Diseases | 1 | 2017 | 1150 | 0.31 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.30 | Why? |
| Oropharynx | 3 | 2021 | 1581 | 0.26 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.24 | Why? |
| Vulvar Diseases | 2 | 2018 | 38 | 0.22 | Why? |
| Dengue | 3 | 2019 | 1565 | 0.22 | Why? |
| Chromatography | 1 | 2021 | 112 | 0.21 | Why? |
| Dengue Virus | 2 | 2018 | 910 | 0.20 | Why? |
| Leptospirosis | 1 | 2021 | 103 | 0.20 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.19 | Why? |
| Malaria, Vivax | 1 | 2020 | 152 | 0.19 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.18 | Why? |
| Respiratory Tract Infections | 1 | 2019 | 6817 | 0.18 | Why? |
| Connexin 26 | 1 | 2017 | 9 | 0.18 | Why? |
| Evoked Potentials, Auditory, Brain Stem | 1 | 2017 | 42 | 0.18 | Why? |
| Connexins | 1 | 2017 | 30 | 0.17 | Why? |
| Herpes Genitalis | 1 | 2018 | 90 | 0.17 | Why? |
| Cardiomyopathy, Dilated | 1 | 2020 | 251 | 0.17 | Why? |
| Condylomata Acuminata | 1 | 2017 | 62 | 0.17 | Why? |
| Acute-On-Chronic Liver Failure | 1 | 2020 | 237 | 0.17 | Why? |
| Ulcer | 1 | 2018 | 128 | 0.16 | Why? |
| Precancerous Conditions | 1 | 2017 | 108 | 0.16 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2021 | 13720 | 0.15 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.15 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.14 | Why? |
| Population Groups | 1 | 2017 | 212 | 0.14 | Why? |
| Neonatal Screening | 1 | 2017 | 285 | 0.13 | Why? |
| Syphilis | 1 | 2018 | 318 | 0.13 | Why? |
| Infectious Disease Incubation Period | 1 | 2021 | 1033 | 0.13 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.13 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.12 | Why? |
| Platelet Activation | 1 | 2017 | 660 | 0.12 | Why? |
| Rural Health Services | 1 | 2018 | 496 | 0.11 | Why? |
| Infant | 4 | 2021 | 30274 | 0.11 | Why? |
| Comorbidity | 5 | 2021 | 34796 | 0.11 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.11 | Why? |
| Anesthesia | 1 | 2020 | 1236 | 0.10 | Why? |
| Patient Compliance | 1 | 2019 | 1468 | 0.09 | Why? |
| Child | 5 | 2021 | 70012 | 0.09 | Why? |
| Liver Cirrhosis | 1 | 2020 | 1810 | 0.09 | Why? |
| Papillomavirus Infections | 1 | 2017 | 861 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.09 | Why? |
| Rural Population | 2 | 2018 | 2408 | 0.09 | Why? |
| Mass Vaccination | 1 | 2018 | 1101 | 0.09 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.08 | Why? |
| Humans | 27 | 2021 | 930598 | 0.08 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.08 | Why? |
| Quality Improvement | 1 | 2019 | 2435 | 0.08 | Why? |
| Male | 14 | 2021 | 367725 | 0.08 | Why? |
| Coinfection | 3 | 2020 | 6820 | 0.07 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.07 | Why? |
| Thrombocytopenia | 1 | 2017 | 2093 | 0.06 | Why? |
| Prospective Studies | 2 | 2019 | 43301 | 0.06 | Why? |
| Pharynx | 2 | 2021 | 1544 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.06 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.05 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.05 | Why? |
| Female | 10 | 2021 | 380317 | 0.05 | Why? |
| Fatal Outcome | 2 | 2020 | 3438 | 0.05 | Why? |
| Adult | 8 | 2021 | 244371 | 0.05 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.05 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.05 | Why? |
| Therapeutic Irrigation | 1 | 2021 | 167 | 0.05 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Lidocaine | 1 | 2020 | 94 | 0.05 | Why? |
| Aged | 6 | 2021 | 215776 | 0.05 | Why? |
| Plasmodium vivax | 1 | 2020 | 154 | 0.05 | Why? |
| Heart Failure | 1 | 2020 | 6638 | 0.05 | Why? |
| Treponema pallidum | 1 | 2018 | 42 | 0.04 | Why? |
| Penile Diseases | 1 | 2017 | 15 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2020 | 605 | 0.04 | Why? |
| Herpesvirus 2, Human | 1 | 2018 | 137 | 0.04 | Why? |
| Anus Diseases | 1 | 2017 | 55 | 0.04 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
| Prevalence | 1 | 2019 | 25773 | 0.04 | Why? |
| Perineum | 1 | 2017 | 70 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.04 | Why? |
| Quality Control | 1 | 2020 | 628 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Phagocytosis | 1 | 2017 | 409 | 0.04 | Why? |
| Photography | 1 | 2017 | 255 | 0.04 | Why? |
| Nasal Cavity | 1 | 2020 | 909 | 0.03 | Why? |
| Complement C3 | 1 | 2017 | 271 | 0.03 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.03 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.03 | Why? |
| Sequence Alignment | 1 | 2020 | 2109 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
| Polymerase Chain Reaction | 2 | 2018 | 6740 | 0.03 | Why? |
| Cytomegalovirus | 1 | 2018 | 600 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.03 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Ventricular Function, Left | 1 | 2020 | 1555 | 0.03 | Why? |
| Community Participation | 1 | 2018 | 605 | 0.03 | Why? |
| Travel | 2 | 2020 | 7220 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2018 | 1562 | 0.03 | Why? |
| Platelet Count | 1 | 2017 | 1381 | 0.03 | Why? |
| Diabetic Ketoacidosis | 1 | 2018 | 622 | 0.03 | Why? |
| Stroke Volume | 1 | 2020 | 2153 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Hospitals | 2 | 2020 | 11793 | 0.02 | Why? |
| Heart Arrest | 1 | 2020 | 1239 | 0.02 | Why? |
| Kidney Diseases | 1 | 2021 | 1434 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| China | 3 | 2021 | 50654 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.02 | Why? |
| Iran | 1 | 2020 | 5467 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2019 | 2844 | 0.02 | Why? |
| Guideline Adherence | 1 | 2019 | 2309 | 0.02 | Why? |
| World Health Organization | 1 | 2019 | 4213 | 0.02 | Why? |
| Blood Platelets | 1 | 2017 | 1704 | 0.02 | Why? |
| Italy | 2 | 2020 | 38444 | 0.02 | Why? |
| Liver Diseases | 1 | 2021 | 2698 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Monocytes | 1 | 2017 | 2978 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Fever | 1 | 2018 | 7795 | 0.01 | Why? |
| Phylogeny | 1 | 2020 | 13341 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.01 | Why? |
| Animals | 1 | 2020 | 78931 | 0.01 | Why? |